SLV
SELVITA
GPW
LISTED
source: current reports (ESPI/EBI) · incomplete data — not every contract is disclosed · 4 contracts in the database
DISCLOSED VALUE 12M
Sum of the value of contracts from the last 12 months where the company disclosed an amount; contracts with no disclosed value are excluded.
11.7 m EUR
2 of 2 contracts
SHARE OF REVENUE 12M
Disclosed contract value relative to the company's revenue; computed only when both figures are in PLN.
—
currency other than PLN
LARGEST COUNTERPARTY
57.3%
jedna z największych firm biofarmaceutycznych na świecie
LONGEST TERM
1 year
until 2026
No contracts in this category.
The registry is built from significant-contract announcements — none of this company's contracts carries the selected status.
Portfolio summary
Contracts
4
Active
4
Total value
16.5 m USD
Average value
16.5 m USD
Since
January 29, 2026
Where this data comes from
Contracts come from current reports (ESPI/EBI) — the company discloses only those exceeding its materiality threshold. The list is by definition incomplete.
Status — inferred from the event type and the term's end date, not a dedicated source field.
Share of revenue 12M — only when both the contracts' dominant currency and the company's reporting currency are PLN, with no currency conversion.